<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about ICLR</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Sun, 19 May 2013 09:50:24 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=ICLR" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/covance-beats-earnings-rev-ups-view-analyst-blog-cm243806">
      <guid isPermaLink="false">243806</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jskF7HmZWM4/covance-beats-earnings-rev-ups-view-analyst-blog-cm243806</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Covance Beats Earnings, Rev, Ups View - Analyst Blog</title>
      <description>Covance Inc.  (  CVD  ) reported adjusted  earnings per share of 75 cents in the first quarter of 2013,  beating the year-ago results by 25% and the Zacks Consensus  Estimate by 4.2%. &lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/jskF7HmZWM4" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 06 May 2013 17:15:01 Z</pubDate>
      <a10:updated>2013-05-06T13:30:17Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CVD</nasdaq:tickers>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
      <nasdaq:tickers>MDAS</nasdaq:tickers>
      <nasdaq:tickers>OMCL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/covance-beats-earnings-rev-ups-view-analyst-blog-cm243806</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/new-version-of-impact-ctms-in-market-analyst-blog-cm234317">
      <guid isPermaLink="false">234317</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-xgK89tO8vo/new-version-of-impact-ctms-in-market-analyst-blog-cm234317</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>New Version of IMPACT CTMS in Market - Analyst Blog</title>
      <description>Recently, a subsidiary of  PAREXEL International Corp  (  PRXL  ), Perceptive Informatics, introduced an upgraded version of its IMPACT clinical trial management system (CTMS). IMPACT CTMS&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/-xgK89tO8vo" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 06 Apr 2013 03:08:11 Z</pubDate>
      <a10:updated>2013-04-06T00:07:22Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AIRM</nasdaq:tickers>
      <nasdaq:tickers>CTRX</nasdaq:tickers>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
      <nasdaq:tickers>PRXL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/new-version-of-impact-ctms-in-market-analyst-blog-cm234317</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/longterm-deals-with-drug-makers-help-icons-earnings-cm224097">
      <guid isPermaLink="false">224097</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p2yl3wzr3n0/longterm-deals-with-drug-makers-help-icons-earnings-cm224097</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>Long-Term Deals With Drug Makers Help Icon's Earnings</title>
      <description>Publicly traded outsourcing companies have had their share of   success on Wall Street.      No surprise, really, because the value proposition is   compelling. Who doesn't want to save&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/p2yl3wzr3n0" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 07 Mar 2013 00:00:00 Z</pubDate>
      <a10:updated>2013-03-07T12:55:56Z</a10:updated>
      <author>Investor's Business Daily</author>
      <nasdaq:tickers>BMY</nasdaq:tickers>
      <nasdaq:tickers>CVD</nasdaq:tickers>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>PRXL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/longterm-deals-with-drug-makers-help-icons-earnings-cm224097</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/virtualscopics-reaches-the-black-in-4q-analyst-blog-cm123072">
      <guid isPermaLink="false">123072</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x66HsrqjWaQ/virtualscopics-reaches-the-black-in-4q-analyst-blog-cm123072</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>VirtualScopics Reaches the Black in 4Q - Analyst Blog</title>
      <description>Medical imaging solutions provider   VirtualScopics   (   VSCP   ) posted breakeven earnings a share in fourth-quarter 2011. The New York-based company swung to a profit in the quarter on flat&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/x66HsrqjWaQ" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 25 Feb 2012 00:09:01 Z</pubDate>
      <a10:updated>2012-02-24T21:07:35Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BIOC</nasdaq:tickers>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
      <nasdaq:tickers>VSCP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/virtualscopics-reaches-the-black-in-4q-analyst-blog-cm123072</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/virtualscopics-ppd-expand-ties-analyst-blog-cm117458">
      <guid isPermaLink="false">117458</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wvhd-hDHQe0/virtualscopics-ppd-expand-ties-analyst-blog-cm117458</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>VirtualScopics, PPD Expand Ties - Analyst Blog</title>
      <description>Medical imaging solution provider   VirtualScopics   (   VSCP   ) has expanded its strategic collaboration with North Carolina-based leading contract research organization ("CRO")&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/wvhd-hDHQe0" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 31 Jan 2012 03:41:01 Z</pubDate>
      <a10:updated>2012-01-31T00:41:39Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BIOC</nasdaq:tickers>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
      <nasdaq:tickers>VSCP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/virtualscopics-ppd-expand-ties-analyst-blog-cm117458</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/eu-treaty-fallout-10-stocks-that-may-buck-the-trend-cm109518">
      <guid isPermaLink="false">109518</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oe6G2X8b068/eu-treaty-fallout-10-stocks-that-may-buck-the-trend-cm109518</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Economy</category>
      <category>Stocks</category>
      <title>EU Treaty Fallout: 10 Stocks That May Buck the Trend</title>
      <description>(Written by Rebecca Lipman.   List compiled by Alexander Crawford. Institutional   data sourced from Fidelity.)   EU leaders are imposing waves of spending cuts and tax hikes to show&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/oe6G2X8b068" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 17 Dec 2011 03:27:49 Z</pubDate>
      <a10:updated>2011-12-16T22:27:52Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>ASMI</nasdaq:tickers>
      <nasdaq:tickers>ASPS</nasdaq:tickers>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
      <nasdaq:tickers>IHG</nasdaq:tickers>
      <nasdaq:tickers>MTD</nasdaq:tickers>
      <nasdaq:tickers>SBLK</nasdaq:tickers>
      <nasdaq:tickers>ST</nasdaq:tickers>
      <nasdaq:tickers>TRNX</nasdaq:tickers>
      <nasdaq:tickers>TX</nasdaq:tickers>
      <nasdaq:tickers>VIP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/eu-treaty-fallout-10-stocks-that-may-buck-the-trend-cm109518</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bearish-macd-for-iclr-tale-of-the-tape-cm107336">
      <guid isPermaLink="false">107336</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YsTJGSLWUAM/bearish-macd-for-iclr-tale-of-the-tape-cm107336</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Bearish MACD for ICLR  - Tale of the Tape</title>
      <description>ICON plc   's (   ICLR   ) MACD indicator has moved into bearish territory with a reading of -0.0639. The Zacks #5 Rank ("Strong Sell") stock decreased more than 2%16.22 in morning&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/YsTJGSLWUAM" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 07 Dec 2011 19:57:01 Z</pubDate>
      <a10:updated>2011-12-07T16:02:49Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bearish-macd-for-iclr-tale-of-the-tape-cm107336</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/top-goldman-sachs-analyst-sovereign-risk-is-spreading-like-wildfire-cm105376">
      <guid isPermaLink="false">105376</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LuykjhgseeE/top-goldman-sachs-analyst-sovereign-risk-is-spreading-like-wildfire-cm105376</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <category>US Markets</category>
      <title>Top Goldman Sachs Analyst: Sovereign Risk is Spreading Like Wildfire</title>
      <description>(Written by Rebecca Lipman.   List compiled by Eben Esterhuizen, CFA )  The situation in Europe is bleak, and the European Monetary Union is racing to construct ‘firewalls’ to mitigate&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LuykjhgseeE" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 29 Nov 2011 06:33:55 Z</pubDate>
      <a10:updated>2011-11-29T01:33:56Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>AMRN</nasdaq:tickers>
      <nasdaq:tickers>ASMI</nasdaq:tickers>
      <nasdaq:tickers>ASPS</nasdaq:tickers>
      <nasdaq:tickers>DCIX</nasdaq:tickers>
      <nasdaq:tickers>ICLR</nasdaq:tickers>
      <nasdaq:tickers>IHG</nasdaq:tickers>
      <nasdaq:tickers>MTD</nasdaq:tickers>
      <nasdaq:tickers>SBLK</nasdaq:tickers>
      <nasdaq:tickers>TRNX</nasdaq:tickers>
      <nasdaq:tickers>TX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/top-goldman-sachs-analyst-sovereign-risk-is-spreading-like-wildfire-cm105376</feedburner:origLink></item>
  </channel>
</rss>
